Management of F75 Feeding in Pediatric Severe Acute Malnutrition
F75 is a low-protein, low-energy therapeutic milk formula (75 kcal/100mL, 0.9g protein/100mL) used during the initial stabilization phase of severe acute malnutrition treatment for 2-7 days before transitioning to higher-calorie rehabilitation feeds. 1
Stabilization Phase Protocol with F75
Energy and Protein Requirements
- Provide 150 kcal/kg body weight/day during the therapeutic feeding program 2, 3, 4
- Deliver 3 grams of protein/kg body weight/day 2, 3, 4
- Divide feedings into 4-6 small meals per day to maximize tolerance and absorption 2, 3
- For severely ill children or those with poor appetite, 24-hour feeding centers are most effective 2
Duration and Transition Criteria
- Continue F75 for 2-7 days during the stabilization phase 1
- Transition to ready-to-use therapeutic foods (RUTF) or F100 once the child is stabilized and appetite returns 1
- Approximately 65% of children successfully transition from F75 to RUTF on first attempt, with median transition duration of 4 days 5
- Younger children, those with HIV infection, severe wasting, and caregiver-rated severe illness are more likely to fail initial transition 5
Essential Concurrent Interventions
Micronutrient Supplementation
- Administer vitamin A upon admission: 100,000 IU for children under 12 months, with repeat dosing every 3 months 3, 4
- Provide iron syrup if iron deficiency anemia is highly prevalent, at 3 mg/kg/day of elemental iron between meals 3
- Supplement with vitamin C weekly if not included in the ration 2
Infection Management
- Initiate amoxicillin as first-line antibiotic therapy for uncomplicated severe acute malnutrition to reduce mortality and improve nutritional recovery 3, 4
- Check measles immunization status upon admission and vaccinate if needed 2
- Administer mebendazole (two 100mg tablets) with vitamin A if available, but avoid in infants under 12 months 2
Monitoring Requirements
Weight and Progress Tracking
- Weigh children daily initially, then twice weekly once stabilized 2, 3, 4
- Target weight gain of 10 grams/kg body weight/day 2, 3, 4
- Maintain detailed patient register with personal ration card and identification bracelet 2
- Follow up all absentees at home and encourage return to program 2
Discharge Criteria from Stabilization Phase
- Child maintains 80% weight-for-height (Z-score of -2) for 2 weeks 2, 3, 4
- Weight gain occurs without edema 2, 4
- Child is active and free from obvious illness 2, 4
- Child exhibits good appetite 2, 4
Critical Pitfalls and Considerations
Metabolic Complications
- Monitor for refeeding syndrome during early stabilization, as severely malnourished children have impaired metabolic capacity 6
- Watch for hypoglycemia if F75 is abruptly discontinued; use gradual tapering when transitioning 7
- Avoid overfeeding, which increases risk of complications including hyperglycemia and respiratory distress 6, 7
Diarrhea and Malabsorption
- Diarrhea is present in approximately 33% at admission and increases to 48% during transition phase 8
- Standard F75 contains lactose, which may contribute to osmotic diarrhea in children with carbohydrate malabsorption 8, 9
- However, lactose-free, reduced-carbohydrate formulations have not shown superior clinical outcomes in controlled trials 9
Thiamine Deficiency Risk
- The thiamine content of F75 may be insufficient for critically ill children with complicated severe acute malnutrition who have higher thiamine requirements 10
- Consider additional thiamine supplementation in children presenting with shock, sepsis, or multiple comorbidities 10
Special Populations
- HIV-infected children should receive the same therapeutic feeding approach as HIV-uninfected children, though they have higher failure rates during transition 1, 5
- For infants under 6 months, prioritize reinitiating exclusive breastfeeding as the primary therapeutic goal alongside F75 4
- Children requiring nasogastric feeding need trained personnel for safe administration 2